Notice for lutetium-177 non-carrier added supplied as 177LuCl3 (ANSTO t/a ANSTO Health)
Active ingredients
lutetium-177 non-carrier added supplied as 177LuCl3
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Indication
For the treatment of neuroendocrine tumours